Literature DB >> 11145927

New evidence for beneficial effects of statins unrelated to lipid lowering.

W Palinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11145927     DOI： 10.1161/01.atv.21.1.3

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  25 in total

Review 1.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

2.  Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia.

Authors:  Liliana Grigore; Sara Raselli; Katia Garlaschelli; Laura Redaelli; Giuseppe D Norata; Angela Pirillo; Alberico L Catapano
Journal:  Eur J Clin Pharmacol       Date:  2012-07-10       Impact factor: 2.953

Review 3.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.

Authors:  Naoki Sawada; James K Liao
Journal:  Antioxid Redox Signal       Date:  2013-09-24       Impact factor: 8.401

Review 5.  Can statins improve outcomes after isolated cardiac valve surgery? A systematic literature review.

Authors:  Jacob Chacko; Leanne Harling; Hutan Ashrafian; Thanos Athanasiou
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

Review 6.  Pleiotropic effects of statins. - Basic research and clinical perspectives -.

Authors:  Qian Zhou; James K Liao
Journal:  Circ J       Date:  2010-04-15       Impact factor: 2.993

7.  Lipid and C-reactive protein levels, cardiovascular disease risk factors and simvastatin treatment in Brazilian individuals.

Authors:  Alexandre B Rosendo; Luciana O Lima; Felipe Dal-Pizzol; Silvana Almeida
Journal:  Inflammation       Date:  2010-08       Impact factor: 4.092

Review 8.  Associations between statins and COPD: a systematic review.

Authors:  Claudia C Dobler; Keith K Wong; Guy B Marks
Journal:  BMC Pulm Med       Date:  2009-07-12       Impact factor: 3.317

Review 9.  Rho kinase: an important mediator of atherosclerosis and vascular disease.

Authors:  Qian Zhou; James K Liao
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity.

Authors:  S Nagassaki; R D Herculano; C F O Graeff; J E Tanus-Santos
Journal:  Eur J Clin Pharmacol       Date:  2008-12-23       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.